Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 22, 2024 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the...
Seer Appoints Nicolas Roelofs to its Board of Directors
August 14, 2024 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced it has...
Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference
August 09, 2024 07:00 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the...
Seer Reports Second Quarter 2024 Financial Results
August 08, 2024 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported financial...
Seer to Report Second Quarter 2024 Financial Results on August 8, 2024
July 18, 2024 16:03 ET
|
Seer, Inc.
REDWOOD CITY, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it...
Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery
June 11, 2024 11:11 ET
|
Seer, Inc.
Secretome profiles from SpaceX Inspiration4 mission show alterations in oxidative stress, brain homeostasis, and coagulation Creation of first-of-its-kind comprehensive atlas of molecular and...
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
June 02, 2024 10:55 ET
|
Seer, Inc.
REDWOOD CITY, Calif., June 02, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, announced today that...
Seer Reports First Quarter 2024 Financial Results
May 08, 2024 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported financial...
Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions
May 08, 2024 16:03 ET
|
Seer, Inc.
New Seer Technology Access Center to open in Bonn, Germany Provides life sciences researchers conducting proteomic studies full-service access to the Seer Proteograph™ Product Suite and mass...
Seer to Report First Quarter 2024 Financial Results on May 8, 2024
April 23, 2024 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it...